Detalles de la búsqueda
1.
The Relationship Between Health-Related Quality of Life and Overall Survival in Patients With Advanced Renal Cell Carcinoma in CheckMate 214.
Oncologist
; 2024 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38280218
2.
Patient-reported outcomes with cemiplimab monotherapy for first-line treatment of advanced non-small cell lung cancer with PD-L1 of ≥50%: The EMPOWER-Lung 1 study.
Cancer
; 129(1): 118-129, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36308296
3.
Quality of life with cemiplimab plus chemotherapy for first-line treatment of advanced non-small cell lung cancer: Patient-reported outcomes from phase 3 EMPOWER-Lung 3.
Cancer
; 129(14): 2256-2265, 2023 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37151113
4.
Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(2): 292-303, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35032437
5.
The impact of enzalutamide on quality of life in men with metastatic hormone-sensitive prostate cancer based on prior therapy, risk, and symptom subgroups.
Prostate
; 82(13): 1237-1247, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35675470
6.
Patient-reported outcomes following enzalutamide or placebo in men with non-metastatic, castration-resistant prostate cancer (PROSPER): a multicentre, randomised, double-blind, phase 3 trial.
Lancet Oncol
; 20(4): 556-569, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30770294
7.
Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial.
Lancet Oncol
; 20(2): 297-310, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30658932
8.
Validity and performance of the Functional Assessment of Cancer Therapy-Bladder (FACT-Bl) among advanced urothelial cancer patients.
Support Care Cancer
; 27(11): 4189-4198, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30825026
9.
Health-related quality of life effects of enzalutamide in patients with metastatic castration-resistant prostate cancer: an in-depth post hoc analysis of EQ-5D data from the PREVAIL trial.
Health Qual Life Outcomes
; 15(1): 130, 2017 Jun 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-28645287
10.
Effect of enzalutamide on health-related quality of life, pain, and skeletal-related events in asymptomatic and minimally symptomatic, chemotherapy-naive patients with metastatic castration-resistant prostate cancer (PREVAIL): results from a randomised, phase 3 trial.
Lancet Oncol
; 16(5): 509-21, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25888263
11.
Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
BMC Urol
; 15: 41, 2015 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25956727
12.
Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison.
J Antimicrob Chemother
; 69(11): 2892-900, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25074856
13.
Mapping the FACT-P to the preference-based EQ-5D questionnaire in metastatic castration-resistant prostate cancer.
Value Health
; 17(2): 238-44, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24636382
14.
Patient-reported outcomes from the phase 3 ADMIRAL trial in patients with FLT3-mutated relapsed/refractory AML.
Leuk Lymphoma
; 64(5): 938-950, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37019445
15.
Psychometric Validation and Meaningful Change Thresholds of the New Nasal Polyposis Symptom Diary.
Ann Otol Rhinol Laryngol
; 132(12): 1638-1648, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37271980
16.
Measurement Properties of 2 Novel PROs, the Pompe Disease Symptom Scale and Pompe Disease Impact Scale, in the COMET Study.
Neurol Clin Pract
; 13(5): e200181, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37559825
17.
A Matching-adjusted Indirect Comparison of Nivolumab Plus Cabozantinib Versus Pembrolizumab Plus Axitinib in Patients with Advanced Renal Cell Carcinoma.
Eur Urol Oncol
; 6(3): 339-348, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36842942
18.
Validation of the PRUCISION Instruments in Pediatric Patients with Progressive Familial Intrahepatic Cholestasis.
Adv Ther
; 39(11): 5105-5125, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36066745
19.
Impact of enzalutamide on patient-reported fatigue in patients with prostate cancer: data from the pivotal clinical trials.
Prostate Cancer Prostatic Dis
; 25(2): 288-295, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34518652
20.
EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer.
Eur J Cancer
; 174: 299-309, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35922251